Q&A with Arugula Sciences’ Chief Scientific Officer

Written By Kathleen Otto

Ramon Coronado, MS, PhD, Chief Scientific Officer, Arugula Sciences

TELL US ABOUT ARUGULA SCIENCES.

Arugula Sciences is a clinical-stage biotech company with a clear mission of serving patients. We aim to bring novel cellular and biologic therapeutics to the clinic – this mission drives all our work. I am proud to lead our company toward advancing our technological platform for first and best-in-class drugs to help patients with autoimmune and degenerative afflictions. We have three core therapies in our pipeline, with the expectation to have them under clinical trials by the end of this year. And while we have a platform of established assets, we remain a discovery company at heart in many ways.

WHAT IS YOUR VISION FOR ARUGULA SCIENCES, AND HOW ARE YOU NAVIGATING THE COMPANY TOWARDS A SUCCESSFUL FUTURE?

We are very excited about becoming a leading biotech company in the field of regenerative medicine. This field of medicine needs a serious company leader to demonstrate that some of these therapies have a place in the clinic and can provide transforming patient benefits.

Kathleen Otto
Previous

What Will Innovation Look Like in Fort Worth This Year? Companies and Officials Provide Insight
Next

Baylor Designated as National Center of Academic Excellence in Cyber Defense